Dr Reddy#39;s launches cancer treatment injection in US

The company has launched Bortezomib for Injection 3.5 mg/vial, approved by the United States Food and Drug Administration (USFDA) via a new drug application pathway for intravenous use only, Dr Reddy#39;s Laboratories said in a statement.

from Moneycontrol Business News https://ift.tt/35UVNE6